NCT04263844View on ClinicalTrials.gov

Intranasal Dexmedetomidine Versus Intranasal Midazolam for Emergence Delirium Prevention

PHASE4CompletedINTERVENTIONAL
Enrollment

66

Participants

Timeline

Start Date

January 10, 2019

Primary Completion Date

October 10, 2019

Study Completion Date

October 10, 2019

Conditions
Emergence Delirium
Interventions
DRUG

Intranasal dexmedetomidine

subject will receive premedication with intranasal dexmedetomidine thirty minutes before induction

DRUG

Intranasal Midazolam

subject will receive premedication with intranasal midazolam thirty minutes before induction

Trial Locations (1)

10430

Cipto Mangunkusumo Cental National Hospital, Jakarta

All Listed Sponsors
lead

Indonesia University

OTHER

NCT04263844 - Intranasal Dexmedetomidine Versus Intranasal Midazolam for Emergence Delirium Prevention | Biotech Hunter | Biotech Hunter